Skip to content
Home/Companies/Healthcare/Achilles Therapeutics
AT

Achilles Therapeutics

Healthcare·United Kingdom·Exited 2021·Held 5yr

Achilles Therapeutics is a healthcare company, headquartered in United Kingdom.

Entry
2016
Hold
5yr
Exit
2021
Est. EV
–

Who owns Achilles Therapeutics?

Achilles Therapeutics was owned by Albion Capital through Albion Enterprise VCT (2007 vintage) from 2016 to 2021, exited via IPO.

Hand-verified · updated 2026-06-07

Albion Capital
Investor
Albion Capital
Albion Enterprise VCT · 2007 · Evergreen

Key facts

HQUnited Kingdom
SectorHealthcare
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2021

More from Albion Enterprise VCT

Other portfolio companies in the same fund.

Bound
Active
FintechUnited Kingdom· 2026
Agio Ratings
Active
FintechUnited Kingdom· 2025
IONATE
Active
EnergyUK· 2025
Latent Technology
Active
AI/MLUK· 2025
Mondra
Active
ClimateTechUK· 2025
Gridcog
Active
SoftwareUK· 2024

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
4ways
Active
ECI PartnersUK
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abcam (exited)
Active
EMV CapitalUK
Data refreshed weekly · Sourced from public filings